www.fdanews.com/articles/152505-pharma-blog-watch
Pharma Blog Watch
January 18, 2013
Never Mind FDA, States Are Crafting Biosimilar Laws (Pharmalot Blog)
The FDA may not have approved a biosimilar yet or decided whether a biosimilar is interchangeable with a brand biologic, but this is not stopping some state legislatures from considering bills that would allow substitution, blogger Ed Silverman writes. Currently, three states — Virginia, Pennsylvania and Illinois — have legislation in the works that may gain momentum this year.
The FDA may not have approved a biosimilar yet or decided whether a biosimilar is interchangeable with a brand biologic, but this is not stopping some state legislatures from considering bills that would allow substitution, blogger Ed Silverman writes. Currently, three states — Virginia, Pennsylvania and Illinois — have legislation in the works that may gain momentum this year.